Drawing for NUCLEOCORE PLATFORM

USPTO serial 99943564

NUCLEOCORE PLATFORM

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with NUCLEOCORE PLATFORM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

DAVID D. RODRIGUES

DAVID D. RODRIGUES ROBINSON & COLE LLP666 Third Avenue, 20th floorNew York, NY 10017United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals; diagnostic preparations for medical purposes; biological reagents for medical purposes; pharmaceutical preparations for immunity adjustment; anti-cancer preparations; pharmaceutical preparations for the treatment of cancer; vaccines; medicines for the treatment of gastrointestinal diseases; anti-inflammatories; drugs for medical purposes; drug delivery agentsACTIVE—
042Scientific research for medical purposes in the field of cancerous diseases; medical and pharmacological research services; research on the subject of pharmaceuticals; scientific research for medical purposes; technological research; providing paas (platform as a service); providing science technology information; analysis and evaluation of medical product development; research and development of pharmaceutical preparations; research and development of anti-cancer preparations; pharmaceutical research; development of drug formulationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 27, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 16, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 16, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance